Financhill
Back

Medifast Quote, Financials, Valuation and Earnings

Sell
22

MED
Medifast

Last Price:
24.82
Seasonality Move:
18.74%

7 Day Trial

ALL ACCESS PASS

$ 7

Medifast Price Quote

$24.82
+0.02 (+8.72%)
(Updated: May 29, 2024 at 6:14 AM ET)

Medifast Key Stats

Sell
22
Medifast (MED) is a Sell

Day range:
$22.70 - $24.94
52-week range:
$22.35 - $109.52
Dividend yield:
26.57%
P/E ratio:
2.73
P/S ratio:
0.30
P/B ratio:
1.29%

Volume:
830.2K
Avg. volume:
489.7K
1-year change:
-69.79%
Market cap:
$271.2M
Revenue:
$1.1B
EPS:
$6.15

How Much Does Medifast Make?

  • How Much Are Medifast's Sales Annually?
    MED Revenues are $1.1B
  • How Much Profit Does Medifast's Make A Year?
    MED net income is $99.4M

Is Medifast Growing As A Company?

  • What Is Medifast's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.5%
  • What Is Medifast's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.79%

Medifast Stock Price Performance

  • Did Medifast Stock Go Up Last Month?
    Medifast share price went down by -26.43% last month
  • Did MED's Share Price Rise Over The Last Year?
    MED share price fell by -69.79% over the past 1 year

What Is Medifast 52-Week High & Low?

  • What Is Medifast’s 52-Week High Share Price?
    Medifast has traded as high as $109.52 over the past 52 weeks
  • What Is Medifast’s 52-Week Low Share Price?
    Medifast has traded as low as $22.35 over the past 52 weeks

Medifast Price To Free Cash Flow

  • Is Medifast Stock Overvalued?
    Medifast is trading at a price to free cash flow ratio of 3.20
  • Is Medifast Stock Undervalued?
    Medifast EV to Free Cash Flow ratio is 1.36
  • What Is Medifast’s Price Earnings Growth Ratio?
    MED PEG ratio is 0.00
  • Is Medifast Trading At A Premium To Earnings?
    Medifast EV to EBIT ratio is 1.42

Is It Risky To Buy Medifast?

  • How Much Debt Does Medifast Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Medifast Have?
    Cash and short term investments quarterly total is $156.4M
  • What Is Medifast’s Book Value Per Share?
    Book value per share is 19.29

Is Medifast Cash Flow Positive?

  • What Is MED Cash Flow From Operations?
    Cash flow from operations (TTM) is $90.9M
  • What Is Medifast’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$55.4M
  • What Is Medifast’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$61.7M

Medifast Return On Invested Capital

  • Is Management Doing A Good Job?
    MED return on invested capital is 35.22%
  • What Is Medifast Return On Assets?
    ROA measures how assets are converting to revenues and is 21.54%
  • What Is MED Return On Equity?
    ROE is a measure of profitability and is 35.22%

Medifast Earnings Date & Stock Price

  • What Is Medifast's Stock Price Today?
    A single share of MED can be purchased today for 24.80
  • What Is Medifast’s Stock Symbol?
    Medifast trades on the nyse under the ticker symbol: MED
  • When Is Medifast’s Next Earnings Date?
    The next quarterly earnings date for Medifast is scheduled on August 7, 2024
  • When Is MED's next ex-dividend date?
    Medifast's next ex-dividend date is September 18, 2023
  • How To Buy Medifast Stock?
    You can buy Medifast shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Medifast Competitors

  • Who Are Medifast's Competitors?
    Below is a list of companies who compete with Medifast or are related in some way:
    • All American Gold Corp (AAGC)
    • Frontdoor Inc (FTDR)
    • Patrick Industries Inc (PATK)
    • Interactive Strength Inc (TRNR)
    • WW International Inc (WW)

Medifast Dividend Yield

  • What Is MED Dividend Yield?
    Medifast’s dividend yield currently is 26.57%
  • What Is Medifast’s Payout Ratio?
    Medifast’s payout ratio is 80.52%
  • When Did Medifast Last Pay A Dividend?
    The latest dividend pay date is May 29, 2024
  • What Is Medifast’s Dividend Per Share?
    Medifast pays a dividend of $0.00 per share

Medifast Analyst Estimates

YoY Growth Past Surprise
EPS: -79.29% -17.5%
Revenue: -49.93% 0.74%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 25.00
Upside from Last Price: 0.81%

Major Shareholders

  • How many MED shares are owned by institutional investors?
    14.7M MED shares are owned by institutional investors
  • How many MED shares are owned by insiders?
    2.4M MED shares are owned by insiders